Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies. Blood 2018 Mar 29;131(13):1486-1489
Date
02/15/2018Pubmed ID
29439950Pubmed Central ID
PMC5877442DOI
10.1182/blood-2017-10-812461Scopus ID
2-s2.0-85047628793 (requires institutional sign-in at Scopus site) 14 CitationsAuthor List
Curtis BR, Hsu YS, Podoltsev N, Lacy J, Curtis S, Samuel MS, Zutavern K, DeSimone RA, Bougie DW, Aster RHAuthor
Brian Curtis PhD Director in the Platelet & Neutrophil Immunology Laboratory department at BloodCenter of WisconsinMESH terms used to index this publication - Major topics in bold
AgedAutoantibodies
Colonic Neoplasms
Female
Humans
Male
Middle Aged
Purpura, Thrombocytopenic, Idiopathic
Stomach Neoplasms
